Agilent to present precision oncology and digital pathology advances at USCAP 2026

Reuters

Mar 19

Agilent to present precision oncology and digital pathology advances at USCAP 2026

Agilent plans to attend the USCAP Annual Meeting on March 21-26, 2026, in San Antonio, Texas.
A Digital Pathology Symposium titled “Future Ready Total Pathology Workflows: Integrating Advanced Staining and Digital Solutions in Today's Practice” is scheduled for March 23, 2026, 12:00-1:00 p.m., in Seminar Room 7.
A session titled “Gastric Cancer and PD-L1 Expression: Morphology, Biomarker Landscape, and Case Analysis” is scheduled for March 24, 2026, 12:00-1:00 p.m., in Seminar Room 2.
A session titled “PD-L1 in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC): Scoring for a Newly Established Indication” is scheduled for March 25, 2026, 12:00-1:00 p.m., in Seminar Room 2.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agilent Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260319962666) on March 19, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2620247171"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2620247171\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2620247171?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-19 20:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620247171","market":"nz","top_or_hot":-1,"title":"Agilent to present precision oncology and digital pathology advances at USCAP 2026","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Agilent to present precision oncology and digital pathology advances at USCAP 2026\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          Agilent plans to attend the USCAP Annual Meeting on March 21-26, 2026, in San Antonio, Texas.\n        </li>\n<li>\n          A Digital Pathology Symposium titled “Future Ready Total Pathology Workflows: Integrating Advanced Staining and Digital Solutions in Today's Practice” is scheduled for March 23, 2026, 12:00-1:00 p.m., in Seminar Room 7.\n        </li>\n<li>\n          A session titled “Gastric Cancer and PD-L1 Expression: Morphology, Biomarker Landscape, and Case Analysis” is scheduled for March 24, 2026, 12:00-1:00 p.m., in Seminar Room 2.\n        </li>\n<li>\n          A session titled “PD-L1 in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC): Scoring for a Newly Established Indication” is scheduled for March 25, 2026, 12:00-1:00 p.m., in Seminar Room 2.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agilent Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260319962666) on March 19, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Agilent to present precision oncology and digital pathology advances at USCAP 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAgilent to present precision oncology and digital pathology advances at USCAP 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-19 20:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Agilent to present precision oncology and digital pathology advances at USCAP 2026\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          Agilent plans to attend the USCAP Annual Meeting on March 21-26, 2026, in San Antonio, Texas.\n        </li>\n<li>\n          A Digital Pathology Symposium titled “Future Ready Total Pathology Workflows: Integrating Advanced Staining and Digital Solutions in Today's Practice” is scheduled for March 23, 2026, 12:00-1:00 p.m., in Seminar Room 7.\n        </li>\n<li>\n          A session titled “Gastric Cancer and PD-L1 Expression: Morphology, Biomarker Landscape, and Case Analysis” is scheduled for March 24, 2026, 12:00-1:00 p.m., in Seminar Room 2.\n        </li>\n<li>\n          A session titled “PD-L1 in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC): Scoring for a Newly Established Indication” is scheduled for March 25, 2026, 12:00-1:00 p.m., in Seminar Room 2.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agilent Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260319962666) on March 19, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2041044095.USD","symbol_name":"Blackrock Circular Economy A2 USD","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL75023h:1","article_id":"2620247171","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2620247171","pubTimestamp":1773921651,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Agilent plans to attend the USCAP Annual Meeting on March 21-26, 2026, in San Antonio, Texas.A Digital Pathology Symposium titled “Future Ready Total Pathology Workflows: Integrating Advanced Staining and Digital Solutions in Today's Practice” is scheduled for March 23, 2026, 12:00-1:00 p.m., in Seminar Room 7.A session titled “Gastric Cancer and PD-L1 Expression: Morphology, Biomarker Landscape, and Case Analysis” is scheduled for March 24, 2026, 12:00-1:00 p.m., in Seminar Room 2.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agilent Technologies Inc. published the original content used to generate this news brief via Business Wire  on March 19, 2026, and is solely responsible for the information contained therein.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2041044095.USD":"Blackrock Circular Economy A2 USD","IE00BN0W2T93.GBP":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (GBP) ACC","LU1165135440.EUR":"BNP Paribas Aqua Classic Cap EUR","LU2229751404.USD":"ALLIANZ GLOBAL WATER \"AT3\" (USD) ACC","IE00BN0W2W23.USD":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (USD) ACC","LU1543694498.USD":"法巴水资源基金RH MD Dis","LU0347712357.USD":"BNP PARIBAS GLOBAL ENVIRONMENT \"C\" (USD) ACC","LU2413666426.HKD":"BNP PARIBAS GLOBAL ENVIRONMENT \"C\" (HKD) ACC","BK4588":"碎股","LU1721428933.USD":"法巴全球经典环境基金RH MD Dis","BK4567":"ESG概念","BK4585":"ETF&股票定投概念","LU2413666699.HKD":"BNP PARIBAS GLOBAL ENVIRONMENT \"CRH\" (HKDHDG) INC","A":"安捷伦科技","LU2092937221.SGD":"Blackrock Circular Economy A2 SGD-H","IE00BN0W2V16.EUR":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (EUR) ACC","LU2089279066.USD":"ALLIANZ GLOBAL WATER \"AT\" (USD) ACC","BK4121":"生命科学工具和服务"},"translate_title":"安捷伦将在USCAP 2026上展示精准肿瘤学和数字病理学进展","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"A":0.9},"content_text":"Agilent to present precision oncology and digital pathology advances at USCAP 2026\n    \n\n\n          Agilent plans to attend the USCAP Annual Meeting on March 21-26, 2026, in San Antonio, Texas.\n        \n\n          A Digital Pathology Symposium titled “Future Ready Total Pathology Workflows: Integrating Advanced Staining and Digital Solutions in Today's Practice” is scheduled for March 23, 2026, 12:00-1:00 p.m., in Seminar Room 7.\n        \n\n          A session titled “Gastric Cancer and PD-L1 Expression: Morphology, Biomarker Landscape, and Case Analysis” is scheduled for March 24, 2026, 12:00-1:00 p.m., in Seminar Room 2.\n        \n\n          A session titled “PD-L1 in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC): Scoring for a Newly Established Indication” is scheduled for March 25, 2026, 12:00-1:00 p.m., in Seminar Room 2.\n        \n\n\n\n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agilent Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260319962666) on March 19, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}